R&D
Advanced biopharmaceutical development company
Immune Cell
The immune system is a defense system that protects the body from external substances or self-derived materials
by eliminating foreign substances, acquiring adaptive immunity, and removing cancer cells
to maintain a healthy body.
When the immune system does not function properly, diseases such as chronic infections or cancer can develop.
If the immune balance is disrupted, conditions like allergies or autoimmune diseases may arise. Immune cells include macrophages and NK cells, which are involved in innate immunity, as well as T cells and B cells involved in adaptive immunity.
Dendritic cells and gamma delta T cells are involved in both types of immunity.
Our company is currently focusing on developing NK cells among these immune cells. Instead of using cancer antigens for cultivation, we are employing advanced culturing methods using cytokines and other cell-derived additives to establish a large-scale NK cell culture process. Furthermore, we are working to integrate the resulting NK cells with cytomaterial-related technologies to develop more effective advanced biopharmaceuticals.
Our company is currently focusing on developing NK cells among these immune cells. Instead of using cancer antigens for cultivation, we are employing advanced culturing methods using cytokines and other cell-derived additives to establish a large-scale NK cell culture process. Furthermore, we are working to integrate the resulting NK cells with cytomaterial-related technologies to develop more effective advanced biopharmaceuticals.
-
Cancer Cells-Feeder
Use of cancer cells
- - Difficult to remove cancer cells
- - Potential risk of residual cancer cells
- - Unsuitable for the establishment of mass production process
-
PBMCs-Feeder
Use of T cells in PBMC
- - Requirement of a lot of blood burdens patients
- - Inhibition of T cell proliferation - radiation equipment required
- - Need to follow up on residual T cells
-
Feeder-free Cytokine Cocktail
NK cell activation cytokine
- - Can be mass produced with little blood
- - Solves the problems of the existing technology
- - Requires optimal cytokine combination
Advanced Biopharmaceuticals
MYTO NK™
MYTO NK, an immune cell therapy under development by our company, is an anticancer drug that targets non-small cell lung cancer or liver cancer.
Lung cancer and liver cancer are known to be very prevalent in both men and women among cancer incidence rates in Korea.
MYTO NK is a treatment using NK cells and Cytomaterials, and has a superior apoptosis effect on cancer cells than existing NK cell treatments.
MYTO NK is a treatment using NK cells and Cytomaterials, and has a superior apoptosis effect on cancer cells than existing NK cell treatments.
